12-49032946-AGCTGCTGCTGCT-AGCT
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM4BP6_ModerateBS2
The NM_003482.4(KMT2D):c.11750_11758delAGCAGCAGC(p.Gln3917_Gln3919del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.0000516 in 1,549,680 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000092 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000047 ( 0 hom. )
Consequence
KMT2D
NM_003482.4 disruptive_inframe_deletion
NM_003482.4 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.97
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_003482.4.
BP6
Variant 12-49032946-AGCTGCTGCT-A is Benign according to our data. Variant chr12-49032946-AGCTGCTGCT-A is described in ClinVar as [Likely_benign]. Clinvar id is 1994989.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr12-49032946-AGCTGCTGCT-A is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 14 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KMT2D | NM_003482.4 | c.11750_11758delAGCAGCAGC | p.Gln3917_Gln3919del | disruptive_inframe_deletion | 40/55 | ENST00000301067.12 | NP_003473.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KMT2D | ENST00000301067.12 | c.11750_11758delAGCAGCAGC | p.Gln3917_Gln3919del | disruptive_inframe_deletion | 40/55 | 5 | NM_003482.4 | ENSP00000301067.7 |
Frequencies
GnomAD3 genomes AF: 0.0000925 AC: 14AN: 151288Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
14
AN:
151288
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000659 AC: 10AN: 151654Hom.: 0 AF XY: 0.0000625 AC XY: 5AN XY: 80048
GnomAD3 exomes
AF:
AC:
10
AN:
151654
Hom.:
AF XY:
AC XY:
5
AN XY:
80048
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000472 AC: 66AN: 1398276Hom.: 0 AF XY: 0.0000493 AC XY: 34AN XY: 689654
GnomAD4 exome
AF:
AC:
66
AN:
1398276
Hom.:
AF XY:
AC XY:
34
AN XY:
689654
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000925 AC: 14AN: 151404Hom.: 0 Cov.: 33 AF XY: 0.0000947 AC XY: 7AN XY: 73952
GnomAD4 genome
AF:
AC:
14
AN:
151404
Hom.:
Cov.:
33
AF XY:
AC XY:
7
AN XY:
73952
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Kabuki syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 21, 2023 | - - |
KMT2D-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 23, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at